Katsuki A, Sumida Y, Murashima S, Fujii M, Ito K, Tsuchihashi K, Murata K, Yano Y, Shima T
Third Department of Internal Medicine, Mie University School of Medicine, Japan.
J Clin Endocrinol Metab. 1996 Jul;81(7):2515-9. doi: 10.1210/jcem.81.7.8675570.
This study was undertaken to investigate the relationship of the serum sex hormone-binding globulin (SHBG) levels with the plasma insulin concentration and with the insulin resistance in male subjects with noninsulin-dependent diabetes mellitus (NIDDM). This investigation comprised 12 patients with NIDDM and 16 normal subjects matched for age, sex, and body mass index (BMI). There was a significant increase in insulin levels (P < 0.03) and a decrease in SHBG levels (P < 0.01) in the diabetic group as compared with those of the normal group. The sex hormone and plasma insulin levels were measured in NIDDM patients undergoing exercise and dietary therapy. Insulin sensitivity was evaluated by the hyperinsulinemic euglycemic clamp technique expressed as the glucose infusion rate (GIR) before and after the treatment. The SHBG levels correlated significantly with the insulin concentrations (r = -0.643, P < 0.05) and with the GIR (r = 0.615, P < 0.05) before the treatment. The SHBG levels (P < 0.02) and GIR (P < 0.01) increased, and the insulin concentrations (P < 0.01) decreased significantly during the treatment. The SHBG levels showed a negative and significant correlation with the plasma insulin concentrations at the end of the clamp study before (r = -0.615, P < 0.05) and after (r = -0.626, P < 0.05) the treatment. These findings suggest that, in the hyperinsulinemic state, plasma insulin has a direct effect on the SHBG levels. SHBG levels decreased significantly during the clamp study before (P < 0.02) and after (P < 0.01) the treatment. This may represent the acute effect of insulin on the SHBG levels. Briefly, these results suggest that insulin may directly affect the SHBG levels and that SHBG may constitute an index of the insulin resistance only in the hyperinsulinemic state.
本研究旨在探讨非胰岛素依赖型糖尿病(NIDDM)男性患者血清性激素结合球蛋白(SHBG)水平与血浆胰岛素浓度及胰岛素抵抗的关系。本研究纳入了12例NIDDM患者和16例年龄、性别及体重指数(BMI)相匹配的正常受试者。与正常组相比,糖尿病组胰岛素水平显著升高(P < 0.03),SHBG水平降低(P < 0.01)。对接受运动和饮食治疗的NIDDM患者测定了性激素和血浆胰岛素水平。通过高胰岛素正常血糖钳夹技术评估胰岛素敏感性,以治疗前后的葡萄糖输注率(GIR)表示。治疗前,SHBG水平与胰岛素浓度显著相关(r = -0.643,P < 0.05),与GIR也显著相关(r = 0.615,P < 0.05)。治疗期间,SHBG水平(P < 0.02)和GIR(P < 0.01)升高,胰岛素浓度(P < 0.01)显著降低。在钳夹研究结束时,治疗前(r = -0.615,P < 0.05)和治疗后(r = -0.626,P < 0.05),SHBG水平与血浆胰岛素浓度均呈显著负相关。这些发现表明,在高胰岛素血症状态下,血浆胰岛素对SHBG水平有直接影响。在钳夹研究中,治疗前(P < 0.02)和治疗后(P < 0.01)SHBG水平均显著降低。这可能代表胰岛素对SHBG水平的急性影响。简而言之,这些结果表明胰岛素可能直接影响SHBG水平,且SHBG可能仅在高胰岛素血症状态下构成胰岛素抵抗的一个指标。